Correlation Between Opus Magnum and Nouveau Life
Can any of the company-specific risk be diversified away by investing in both Opus Magnum and Nouveau Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Magnum and Nouveau Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opus Magnum Ameris and Nouveau Life Pharmaceuticals, you can compare the effects of market volatilities on Opus Magnum and Nouveau Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Magnum with a short position of Nouveau Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Magnum and Nouveau Life.
Diversification Opportunities for Opus Magnum and Nouveau Life
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Opus and Nouveau is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Opus Magnum Ameris and Nouveau Life Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nouveau Life Pharmac and Opus Magnum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Magnum Ameris are associated (or correlated) with Nouveau Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nouveau Life Pharmac has no effect on the direction of Opus Magnum i.e., Opus Magnum and Nouveau Life go up and down completely randomly.
Pair Corralation between Opus Magnum and Nouveau Life
Given the investment horizon of 90 days Opus Magnum is expected to generate 1.21 times less return on investment than Nouveau Life. In addition to that, Opus Magnum is 1.21 times more volatile than Nouveau Life Pharmaceuticals. It trades about 0.06 of its total potential returns per unit of risk. Nouveau Life Pharmaceuticals is currently generating about 0.09 per unit of volatility. If you would invest 0.03 in Nouveau Life Pharmaceuticals on September 5, 2024 and sell it today you would lose (0.03) from holding Nouveau Life Pharmaceuticals or give up 100.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Opus Magnum Ameris vs. Nouveau Life Pharmaceuticals
Performance |
| Timeline |
| Opus Magnum Ameris |
| Nouveau Life Pharmac |
Opus Magnum and Nouveau Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Opus Magnum and Nouveau Life
The main advantage of trading using opposite Opus Magnum and Nouveau Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Magnum position performs unexpectedly, Nouveau Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nouveau Life will offset losses from the drop in Nouveau Life's long position.| Opus Magnum vs. Green Planet Bio | Opus Magnum vs. Azure Holding Group | Opus Magnum vs. Four Leaf Acquisition | Opus Magnum vs. Continental Beverage Brands |
| Nouveau Life vs. Manaris Corp | Nouveau Life vs. Green Planet Bio | Nouveau Life vs. Continental Beverage Brands | Nouveau Life vs. Opus Magnum Ameris |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |